Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromes
Antonio Gutierrez1, Sunil V Rao
1Duke University Medical Center, 2301 Erwin Road, Durham, NC 27710, USA. antonio.gutierrez@duke.edu
Cleveland Clinic Journal of Medicine
|June 3, 2010
Insights
New treatments for acute coronary syndromes reduce ischemic events but increase bleeding risks. This review covers bleeding prevention and management strategies for these patients.
Area of Science:
- Cardiology
- Vascular Medicine
- Pharmacology
Background:
- Non-ST-elevation acute coronary syndromes (NSTE-ACS) management has evolved with antithrombotic and antiplatelet therapies.
- Percutaneous coronary interventions (PCI) are standard for NSTE-ACS, improving ischemic outcomes.
- These advancements, however, are associated with a significant increase in bleeding complications.
Purpose of the Study:
- To review the current scope of bleeding risk in NSTE-ACS patients.
- To discuss strategies for preventing bleeding in this population.
- To outline management approaches for patients experiencing bleeding.
Main Methods:
- Literature review of studies on antithrombotic/antiplatelet therapy in NSTE-ACS.
- Analysis of bleeding risk factors and outcomes.
- Synthesis of current guidelines and expert opinions on bleeding management.
Main Results:
- Ischemic event rates have decreased due to modern therapies.
- Bleeding complications represent a major concern, impacting patient morbidity and mortality.
- Effective prevention and management protocols are crucial for optimizing patient care.
Conclusions:
- Balancing antithrombotic efficacy with bleeding risk is paramount in NSTE-ACS.
- Proactive bleeding risk assessment and mitigation strategies are essential.
- Timely and appropriate management of bleeding events improves patient outcomes.
Abstract:
Antithrombotic and antiplatelet drugs and percutaneous interventions have decreased the ischemic outcomes of non-ST-elevation acute coronary syndromes, but they pose risks of bleeding. The authors review the scope of the problem and ways to prevent and manage bleeding in this situation.
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:26Acute Coronary Syndrome V: Nursing Management
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...